← back to search

Meijing Wu

Emory University · US
Area of research
Oncology · Immunology
Research interest
Research interests include Immune cells in cancer, Glioma Diagnosis and Treatment, Neuroinflammation and Neurodegeneration Mechanisms, and Chemokine receptors and signaling.
h-index
20
citations
2,989
works
115
NIH funding
primary concept
email

Recent publications

135 High Tumor Infiltrating Lymphocytes Are Significantly Associated with Increased Pathological Complete Response Rate in Patients with Triple Negative Breast Cancer and Treated with Neoadjuvant KEYNOTE 522 Chemoimmunotherapy
Laboratory Investigation 2025cited by 0position: middledoi
Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn’s Disease
Inflammatory Bowel Diseases 2019cited by 41position: middledoi
Mutant IDH1 and seizures in patients with glioma
Neurology 2017cited by 255position: middledoi
Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression
Proceedings of the National Academy of Sciences 2017cited by 120position: middledoi
CSF inflammatory response after intraventricular hemorrhage
Neurology 2017cited by 58position: middledoi
Mutant IDH1 and thrombosis in gliomas
Acta Neuropathologica 2016cited by 174position: middledoi
Cell-Penetrating Peptide-Modified Gold Nanoparticles for the Delivery of Doxorubicin to Brain Metastatic Breast Cancer
Molecular Pharmaceutics 2016cited by 122position: middledoi
Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations
Journal of neurosurgery 2016cited by 61position: middledoi
B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models
Journal of Neuroimmune Pharmacology 2016cited by 54position: middledoi
Peripheral Plasma Vitamin D and Non-HDL Cholesterol Reflect the Severity of Cerebral Cavernous Malformation Disease
Biomarkers in Medicine 2016cited by 49position: middledoi
Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters
Journal of Translational Medicine 2016cited by 18position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lingjiao Zhang · Warren County Community College4 papers (2016–2016)Robert Shenkar · University of Chicago3 papers (2016–2016)Maciej S. Lesniak · Northwestern University3 papers (2016–2017)Issam A. Awad · University of Chicago3 papers (2016–2016)Maged D Fam · Oasis Hospital3 papers (2016–2016)Romuald Girard · Txcell (France)3 papers (2016–2016)Changbin Shi · Harbin Medical University3 papers (2016–2016)Hussein A. Zeineddine · The University of Texas Health Science Center3 papers (2016–2016)Laith Khoury · New York University2 papers (2016–2017)Michael Jesselson · Rush University Medical Center2 papers (2016–2016)Matija Snuderl · NYU Langone Health2 papers (2016–2017)Yu Han · Northwestern University2 papers (2016–2017)Priya Kumthekar · Northwestern University2 papers (2016–2017)Dou Yu · Ningbo University2 papers (2016–2017)Cheddhi Thomas · New York University2 papers (2016–2017)Ying Cao · Nanjing Agricultural University2 papers (2016–2016)Atique U. Ahmed · Northwestern University2 papers (2016–2017)Craig Horbinski · Northwestern University2 papers (2016–2017)John G. Golfinos · New York University2 papers (2016–2017)Brenda Auffinger · Johns Hopkins University2 papers (2016–2016)